Director Bailey Reports a Million-Dollar BHVN Buy
April 26, 2024
Here’s The Hot Corner, with data through April 25, 2024:
Fairmount Funds Management filed a 13D for Spyre Therapeutics $SYRE revealing an increase in ownership from 3.25% to 11.17%.
Have a great weekend. We'll be back on Monday with more insider activity.
Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.
And please reach out with any questions. We love hearing from you!
All Star Charts Team